ALK rearrangement testing and treatment patterns for patients with ALK-positive non-small cell lung cancer

In this sample, ALK+ NSCLC patients were racially diverse with mixed smoking history. One in five patients were not tested before first-line therapy. Oncologists reported being more likely to consider ALK testing for patients with particular smoking and race characteristics.